Related Experiment Video
Updated: Sep 14, 2025
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Dose-Dependent Effects of TGF-β Inhibition on Osteoblast Differentiation and Wound Healing
Nihal Almuraikhi1, Latifa Alkhamees1, Sumaiya Tareen1
1Stem Cell Unit, Department of Anatomy, College of Medicine, King Saud University, Riyadh 11461, Saudi Arabia.
Abstract:
TGF-β is a multifunctional pathway that controls significant cellular and physiological processes and several pathological activities. TGF-β-induced signaling can be triggered upon binding to specific receptors to initiate the transcriptional activation of several genes and cellular processes. However, the detailed role of TGF-β signaling in osteoblast differentiation remains to be explicated. SB525334, a selective TGF-βRI inhibitor, was investigated for its effect on the osteoblastic differentiation of human bone marrow MSCs at different concentrations. Alkaline phosphatase (ALP) activity was used to assess osteoblast differentiation marker, while Alizarin red staining was used as a marker for mineralization. Expressions of osteoblast-specific genes were evaluated using real-time PCR. A migration assay was performed to assess the effect of TGF-β on wound healing. Moreover, immunofluorescent staining for SMAD2/3 and SMAD4 was employed to confirm the activation of the TGF-β pathway. The inhibition of TGF-β1 signaling using a high concentration of SB525334 (3 µM) significantly reduced ALP activity and mineralization and downregulated osteoblast-specific genes. However, the opposite effect was reported using a lower concentration (0.03 µM), where osteoblast-associated genes were significantly upregulated, and ALP activity and mineralization were higher. Significant scratch/wound healing was achieved at a lower concentration of SB525334, while a higher concentration of SB525334 resulted in lower healing. Moreover, a low concentration of SB525334 demonstrated nuclear translocation of SMAD 2/3 and 4. Our study confirms that the effect of TGF-β signaling in bone formation and wound healing is dose-dependent, and the use of TGF-β is recommended as a valuable therapeutic approach.
Insights
Transforming growth factor-beta (TGF-β) signaling impacts bone formation and wound healing. Its effects are dose-dependent, with low concentrations promoting osteoblast differentiation and healing, while high concentrations inhibit these processes.
Area of Science:
- Cell Biology
- Biochemistry
- Regenerative Medicine
Background:
- Transforming growth factor-beta (TGF-β) is a key regulator of cellular processes, including osteoblast differentiation and wound healing.
- The precise role of TGF-β signaling in osteoblast differentiation requires further elucidation.
- SB525334 is a selective inhibitor of TGF-β receptor I (TGF-βRI).
Purpose of the Study:
- To investigate the dose-dependent effects of SB525334, a TGF-βRI inhibitor, on the osteoblastic differentiation of human bone marrow mesenchymal stem cells (MSCs).
- To evaluate the impact of TGF-β signaling on bone formation and wound healing processes.
- To confirm the activation of the TGF-β pathway via SMAD proteins.
Main Methods:
- Human bone marrow MSCs were treated with varying concentrations of SB525334.
- Osteoblast differentiation was assessed by alkaline phosphatase (ALP) activity and Alizarin red staining for mineralization.
- Osteoblast-specific gene expression was quantified using real-time PCR.
- Cell migration was evaluated using a scratch/wound healing assay.
- SMAD2/3 and SMAD4 activation was confirmed via immunofluorescent staining.
Main Results:
- High concentrations (3 µM) of SB525334 significantly reduced ALP activity, mineralization, and downregulated osteoblast-specific genes.
- Low concentrations (0.03 µM) of SB525334 significantly upregulated osteoblast-associated genes, enhancing ALP activity and mineralization.
- Low SB525334 concentration promoted significant wound healing, whereas high concentration impaired it.
- Low SB525334 concentration induced nuclear translocation of SMAD 2/3 and 4, indicating pathway activation.
Conclusions:
- TGF-β signaling exerts dose-dependent effects on bone formation and wound healing.
- Low concentrations of TGF-β signaling promote osteoblast differentiation and tissue repair.
- Targeted modulation of TGF-β signaling represents a potential therapeutic strategy for bone regeneration and wound healing.
Related Concept Videos
01:16TGF - β Signaling Pathway
01:17Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...